Lying about BLIPS

Discussion in 'Gilead Sciences' started by anonymous, Nov 13, 2020 at 6:24 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    BLIPS all over the place on Biktarvy.

    When will the deception and lies stop and Gilead employees get morals and values?

    patients are at risk because of breakthrough and failures- when will your next cover up drug come out to stop this?
     

  2. anonymous

    anonymous Guest

    The only blips are in Viiv paychecks from Dovato causing failure more times than you can circulate this fake news on blips.
     
  3. anonymous

    anonymous Guest

    The only blip I see is when an ignorant doctor is fooled into writing Dovato-fortunately that is very rare and much less than even ViiV’s most pessimistic projections- enjoy the layoffs. The only product being used less is that joke of a shot launched in 2019 by ViiV
     
  4. anonymous

    anonymous Guest

    Right keep telling yourself that. Think about how you’ll sound if you’re around to launch your injectable. hey read the world news on the proven superior product to your prep drug. Bye ✌️
     
  5. anonymous

    anonymous Guest

    it’s amazing how clinically inept Viiv reps and strategy are. Try reading the package insert to understand just how great Gilead products are and how Viiv’s serve as much purpose as Stavudine in today’s market.

    Injectables will be a different story all together.
     
  6. anonymous

    anonymous Guest

    Sounds very similar to what you were saying when you launched your 2DR. Remember “standard of care” and the “new gold standard” as you hired 3 idiots per territory? Years in, how is that working out? Have You bought a 3% market share yet? We are near a 50% with Biktarvy. Your 2019, errr 2020, errr 2021 shot might get a little business, until much better shots come out a couple months later. Keep your head on a swivel, ViiV is making Billions less than expected and layoffs are coming.
     
  7. anonymous

    anonymous Guest

    right- or doctors are about to see through your bullshit. Hey we have replacement products for our TDF products that had no issues for patients to be on. Oh and our TDF prep the TAF version makes us more money so use that not the generic. The new single tablet is so much better there is nothing else any patient should take, TAF is perfect doesn’t cause weight gain or anything else. Want to be a speaker and get a cash gift card at an ad board ? Let me just pay you for doing a few trials and send you some wine. Shall we go on?
     
  8. anonymous

    anonymous Guest

    that is correct. There is no better single tablet regimen than what Gilead has to offer. Just like car manufacturers improve innovation by landslides or slight, each year so does biotech.

    Clearly you need to sell copiers and leave Viiv as you are simply embarrassing to all those putting in the work for patients.

    ...and gift cards or incentives died out a decade ago just like lamivudine.
     
  9. anonymous

    anonymous Guest

    There is no reason to argue with this gal. ViiV became irrelevant when they launched 2 drugs together and called it “new”. They are the BlackBerry of HIV.
     
  10. anonymous

    anonymous Guest

    Smells like mediocrity in here
     
  11. anonymous

    anonymous Guest

    LOL
    Like the pipeline of “new 2DR” coming out of Gilead? Confused what your point it-your shit smells just as foul as anyone else’s. Grow up.
     
  12. anonymous

    anonymous Guest

    What Gilead lie? No way
     
  13. anonymous

    anonymous Guest

    It’s cool to have a 2 drug regimen...if it doesn’t put patients at risk of resistance...if it’s not repurposing drugs from the 2000’s...if it’s not including a generic component priced at full commercial cost. Viiv has clowns dictating pipeline and strategy and clearly a few folks have bought into it. Much like the circus, they too will be out of business sooner than later.
     
  14. anonymous

    anonymous Guest

    Is ViiV still in business? Only time I hear about them is when my customers are complaining about their reps tripping over each other to sell them absolutely worthless drugs.
     
  15. anonymous

    anonymous Guest


    Ah, the arrogance of a Gilead HIV rep, not too dissimilar to the HCV reps. Your superiority complex is not becoming of you.
     
  16. anonymous

    anonymous Guest

    What resistance? The same one biktarvy patients have ?
     
  17. anonymous

    anonymous Guest

    Yep VIIV focused on the future and the present to help patients
     
  18. anonymous

    anonymous Guest

    M184V is as common as a cold. You do know that takes half of dovato and throws it in the dumpster fire that is viiv? This isn’t taking care of patients in the present and future, it’s finding a solution for something that doesn’t exist.
     
  19. anonymous

    anonymous Guest

    I agree - ViiV finally acknowledging the dangers of Abacavir and removing it to make a “new” product did benefit patient’s, especially the tens of thousands moved off it and onto Biktarvy.
     
  20. anonymous

    anonymous Guest

    What damage has been done by TDF AND TAF